Literature DB >> 20733099

Differential cardiac remodeling in preload versus afterload.

Karl Toischer1, Adam G Rokita, Bernhard Unsöld, Wuqiang Zhu, Georgios Kararigas, Samuel Sossalla, Sean P Reuter, Alexander Becker, Nils Teucher, Tim Seidler, Cornelia Grebe, Lena Preuss, Shamindra N Gupta, Kathie Schmidt, Stephan E Lehnart, Martina Krüger, Wolfgang A Linke, Johannes Backs, Vera Regitz-Zagrosek, Katrin Schäfer, Loren J Field, Lars S Maier, Gerd Hasenfuss.   

Abstract

BACKGROUND: Hemodynamic load regulates myocardial function and gene expression. We tested the hypothesis that afterload and preload, despite similar average load, result in different phenotypes. METHODS AND
RESULTS: Afterload and preload were compared in mice with transverse aortic constriction (TAC) and aortocaval shunt (shunt). Compared with sham mice, 6 hours after surgery, systolic wall stress (afterload) was increased in TAC mice (+40%; P<0.05), diastolic wall stress (preload) was increased in shunt (+277%; P<0.05) and TAC mice (+74%; P<0.05), and mean total wall stress was similarly increased in TAC (69%) and shunt mice (67%) (P=NS, TAC versus shunt; each P<0.05 versus sham). At 1 week, left ventricular weight/tibia length was significantly increased by 22% in TAC and 29% in shunt mice (P=NS, TAC versus shunt). After 24 hours and 1 week, calcium/calmodulin-dependent protein kinase II signaling was increased in TAC. This resulted in altered calcium cycling, including increased L-type calcium current, calcium transients, fractional sarcoplasmic reticulum calcium release, and calcium spark frequency. In shunt mice, Akt phosphorylation was increased. TAC was associated with inflammation, fibrosis, and cardiomyocyte apoptosis. The latter was significantly reduced in calcium/calmodulin-dependent protein kinase IIdelta-knockout TAC mice. A total of 157 mRNAs and 13 microRNAs were differentially regulated in TAC versus shunt mice. After 8 weeks, fractional shortening was lower and mortality was higher in TAC versus shunt mice.
CONCLUSIONS: Afterload results in maladaptive fibrotic hypertrophy with calcium/calmodulin-dependent protein kinase II-dependent altered calcium cycling and apoptosis. Preload is associated with Akt activation without fibrosis, little apoptosis, better function, and lower mortality. This indicates that different loads result in distinct phenotype differences that may require specific pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733099      PMCID: PMC2955196          DOI: 10.1161/CIRCULATIONAHA.110.943431

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

1.  The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.

Authors:  Johannes Backs; Thea Backs; Stefan Neef; Michael M Kreusser; Lorenz H Lehmann; David M Patrick; Chad E Grueter; Xiaoxia Qi; James A Richardson; Joseph A Hill; Hugo A Katus; Rhonda Bassel-Duby; Lars S Maier; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 2.  Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction.

Authors:  Wolfgang A Linke
Journal:  Cardiovasc Res       Date:  2008-03-01       Impact factor: 10.787

Review 3.  The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.

Authors:  W Matthijs Blankesteijn; Veerle A M van de Schans; Paul ter Horst; Jos F M Smits
Journal:  Trends Pharmacol Sci       Date:  2008-03-14       Impact factor: 14.819

4.  MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.

Authors:  Jinghai Wu; Xiao-Ping Ren; Xiaohong Wang; Maureen A Sartor; Keith Jones; Jiang Qian; Persoulla Nicolaou; Tracy J Pritchard; Guo-Chang Fan
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

5.  Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.

Authors:  Haiyun Ling; Tong Zhang; Laetitia Pereira; Christopher Kable Means; Hongqiang Cheng; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Ju Chen; Donald Bers; Joan Heller Brown; Joan Heller Brown
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

6.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

7.  Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes.

Authors:  Christian Faul; Ashwini Dhume; Alison D Schecter; Peter Mundel
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

8.  Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog.

Authors:  Junying Zheng; Yuanwen Chen; Betty Pat; Louis A Dell'italia; Michael Tillson; A Ray Dillon; Pamela C Powell; Ke Shi; Neil Shah; Thomas Denney; Ahsan Husain; Louis J Dell'Italia
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

9.  Elevated afterload, neuroendocrine stimulation, and human heart failure increase BNP levels and inhibit preload-dependent SERCA upregulation.

Authors:  Karl Toischer; Harald Kögler; Gero Tenderich; Cornelia Grebe; Tim Seidler; Phuc Nguyen Van; Klaus Jung; Ralph Knöll; Reiner Körfer; Gerd Hasenfuss
Journal:  Circ Heart Fail       Date:  2008-09-17       Impact factor: 8.790

10.  MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure.

Authors:  Thomas Thum; Paolo Galuppo; Christian Wolf; Jan Fiedler; Susanne Kneitz; Linda W van Laake; Pieter A Doevendans; Christine L Mummery; Jürgen Borlak; Axel Haverich; Carina Gross; Stefan Engelhardt; Georg Ertl; Johann Bauersachs
Journal:  Circulation       Date:  2007-07-02       Impact factor: 29.690

View more
  114 in total

1.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

Review 2.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

3.  Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction.

Authors:  Eva Wagner; Marcel A Lauterbach; Tobias Kohl; Volker Westphal; George S B Williams; Julia H Steinbrecher; Jan-Hendrik Streich; Brigitte Korff; Hoang-Trong M Tuan; Brian Hagen; Stefan Luther; Gerd Hasenfuss; Ulrich Parlitz; M Saleet Jafri; Stefan W Hell; W Jonathan Lederer; Stephan E Lehnart
Journal:  Circ Res       Date:  2012-06-21       Impact factor: 17.367

Review 4.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

5.  Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.

Authors:  Karl Toischer; Wuqiang Zhu; Mark Hünlich; Belal A Mohamed; Sara Khadjeh; Sean P Reuter; Katrin Schäfer; Deepak Ramanujam; Stefan Engelhardt; Loren J Field; Gerd Hasenfuss
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

6.  Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Mei Methawasin; Joshua G Strom; Rebecca E Slater; Vanessa Fernandez; Chandra Saripalli; Henk Granzier
Journal:  Circulation       Date:  2016-09-14       Impact factor: 29.690

7.  Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.

Authors:  Ichiro Shiojima; Stephan Schiekofer; Jochen G Schneider; Kurt Belisle; Kaori Sato; Martin Andrassy; Gennaro Galasso; Kenneth Walsh
Journal:  Am J Pathol       Date:  2012-09-30       Impact factor: 4.307

8.  Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.

Authors:  Roberto Papait; Paola Cattaneo; Paolo Kunderfranco; Carolina Greco; Pierluigi Carullo; Alessandro Guffanti; Valentina Viganò; Giuliano Giuseppe Stirparo; Michael V G Latronico; Gerd Hasenfuss; Ju Chen; Gianluigi Condorelli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

Review 9.  New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).

Authors:  Adam G Rokita; Mark E Anderson
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

Review 10.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.